SCHEMBL30900213

SCHEMBL30900213

CCCCCCCCC(CCCCCC)CC(=O)N(C)CC(=O)OCCCCCC(CCCCCOC(=O)C(CCCCCC)CCCCCCCC)NCCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TLR2 O60603 2/20 0.32
▸ TLR1 Q15399 2/20 0.32
▸ MMP2 P08253 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ PPARG P37231 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30900164 1.00 TLR2 (0.32) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900193 0.95 TLR2 (0.33) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900168 0.94 PPARG (0.35) TLR2TLR1PPARG
SCHEMBL30900214 0.92 TLR2 (0.32) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900209 0.92 TLR2 (0.32) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900231 0.91 TLR2 (0.34) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900148 0.91 TLR2 (0.34) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900159 0.91 TLR2 (0.34) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900226 0.90 TLR2 (0.33) TLR2TLR1MMP2MMP9MMP12
SCHEMBL30900235 0.89 TLR2 (0.32) TLR2TLR1MMP2MMP9MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594293-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS Nanovation Therapeutics Inc. (CA) 2025-08-06 — — EP disclosed
WO-2024065043-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-04-04 — — WO disclosed
Send feedback